Offer - Urjas Oil for just ₹ 1 X
Niftran is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Niftran safe for pregnant women?
Niftran is safe to take during pregnancy.
Is the use of Niftran safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Niftran. Immediately discontinue Niftran if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Niftran on the Kidneys?
Niftran may have mild side effects on the kidneys.
What is the effect of Niftran on the Liver?
Very few cases of side effects of Niftran on the liver have been reported.
What is the effect of Niftran on the Heart?
Niftran has very mild side effects on the heart.
Niftran should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Niftran unless your doctor advises you to do so -
Is this Niftran habit forming or addictive?
Forming a habit of Niftran has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Niftran can make you feel drowsy.
Is it safe?
Yes, Niftran is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Niftran cannot treat any kind of mental disorder.
Interaction between Food and Niftran
Taking Niftran with food does not harm your health.
Interaction between Alcohol and Niftran
Niftran and alcohol do not lead to side effects, but it is still better to be cautious.
No, Niftran does not cause weight loss. However, if you are experiencing unusual weight loss and you are in doubt that Niftran is causing weight loss then discuss with your doctor instantly.
Yes, Niftran may cause itching (urticaria). It is known side effect of this drug. If you experience excessive itching after taking this drug then do not hesitate to inform your doctor without further delay.
Yes, Niftran can be taken with omeprazole. No harmful drug interaction has been reported between them. However, if you feel any discomfort after taking this drug then do not hesitate to inform your doctor and follow his/her instructions.
Yes Niftran can cause diarrhoea. It is a common side effect of this drug. This condition arises due to an imbalance in the gut flora. Generally, most of the antibiotics kill colonies of "good" as well as "bad bacteria" resulting in the imbalance of microbes causing diarrhoea. You are recommended to avoid heavy and spicy meals along with the intake of this medicine. Also, keep yourself hydrated and take ample rest in case of mild diarrhoea. If you have severe diarrhoea consult with your doctor instantly he/she will prescribe you medicines to stop stool output. After you have completely recovered from diarrhoea you can choose to have a "probiotic" to ensure the re-growth of good bacteria in your gut.
Yes, Niftran can be taken with ibuprofen. No harmful drug interaction has been reported between them. However, if you feel any discomfort after taking this drug do not hesitate to inform your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915